GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectorite Biomedical Inc (ROCO:4170) » Definitions » 3-Year EBITDA Growth Rate

Vectorite Biomedical (ROCO:4170) 3-Year EBITDA Growth Rate : 56.20% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Vectorite Biomedical 3-Year EBITDA Growth Rate?

Vectorite Biomedical's EBITDA per Share for the six months ended in Dec. 2023 was NT$-0.12.

During the past 3 years, the average EBITDA Per Share Growth Rate was 56.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 24.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Vectorite Biomedical was 56.20% per year. The lowest was -16.00% per year. And the median was 28.00% per year.


Competitive Comparison of Vectorite Biomedical's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Vectorite Biomedical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectorite Biomedical's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectorite Biomedical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Vectorite Biomedical's 3-Year EBITDA Growth Rate falls into.



Vectorite Biomedical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Vectorite Biomedical  (ROCO:4170) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Vectorite Biomedical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Vectorite Biomedical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectorite Biomedical (ROCO:4170) Business Description

Traded in Other Exchanges
N/A
Address
Xintai 5th Road, 6th Floor, Number 97, Section 1, Yuzhi District, New Taipei City, Taipei, TWN, 22175
Vectorite Biomedical Inc is a Taiwan-based diagnostic and research company. It prepares studies of adult healthy cells, cell preparation and application.

Vectorite Biomedical (ROCO:4170) Headlines

No Headlines